Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025)
Innoviva (INVA) posted Long-Term Deferred Tax of $8.0 million for Q3 2025, down 38.27% on a QoQ basis from $12.9 million in Q2 2025, and down 46.34% year-over-year from $14.9 million in Q3 2024.
Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends
Innoviva's Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $8.0 million for Q3 2025.
- Quarterly Long-Term Deferred Tax fell 46.34% year-over-year to $8.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.0 million (down 46.34% YoY) and the FY2025 annual result came in at $8.0 million, down 46.34% from the prior year.
- Long-Term Deferred Tax was $8.0 million for Q3 2025 at Innoviva, down from $12.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $74.0 million in Q1 2021 and bottomed at $5.0 million in Q3 2023.
- A 5-year average of $21.2 million and a median of $13.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax sank 81.52% — and 2024, when it jumped 200.38%.
- Innoviva's Long-Term Deferred Tax stood at $17.3 million in 2021, then soared by 34.32% to $23.3 million in 2022, then tumbled by 78.72% to $5.0 million in 2023, then jumped by 143.42% to $12.1 million in 2024, then tumbled by 33.78% to $8.0 million in 2025.
- Business Quant data shows INVA's Long-Term Deferred Tax at $8.0 million in Q3 2025, $12.9 million in Q2 2025, and $12.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 12.93 Mn |
| Mar 31, 2025 | 12.29 Mn |
| Dec 31, 2024 | 12.05 Mn |
| Sep 30, 2024 | 14.88 Mn |
| Jun 30, 2024 | 11.45 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 6.33 Mn |
| Jun 30, 2022 | 23.27 Mn |
| Mar 31, 2022 | 22.40 Mn |
| Dec 31, 2021 | 17.33 Mn |
| Sep 30, 2021 | 28.16 Mn |
| Jun 30, 2021 | 48.69 Mn |
| Mar 31, 2021 | 74.02 Mn |
| Dec 31, 2020 | 93.76 Mn |
| Sep 30, 2020 | 109.49 Mn |
| Jun 30, 2020 | 118.35 Mn |
| Mar 31, 2020 | 138.24 Mn |
| Dec 31, 2019 | 154.17 Mn |
| Sep 30, 2019 | 166.56 Mn |